Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Haemonetics Corp.
Swot
Haemonetics Corp. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Haemonetics Corp. has 14 Strengths, 6 Weaknesses, 5 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(14)
Weakness
(6)
Opportunity
(5)
Threats
(0)
Others
(2)
Stocks in Buy Zone with High Momentum Score Last Month
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Companies with 10% increase in share price over three months, with rising net profit growth
Mid-range Performer (DVM)
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over the Quarter (3 Months)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Month
Annual Net Profits improving for last 2 years
Increasing profits every quarter for the past 2 quarters
RSI indicating price strength
Stocks Outperforming their Industry Price Change in the Quarter
Negative Breakdown Second Support (LTP < S2)
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Top Losers
Negative Breakdown First Support (LTP < S1)
Negative Breakdown Second Support (LTP < S2)
Top Losers
Mutual Funds Increased Shareholding in Past Month
Institutions increasing their shareholding
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Mf buying for 2 months
Promoters increasing shareholding QoQ
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
